Chronic Pain
Conditions
Keywords
self management, e-health, health tech, Digital Pain-Management Tool
Brief summary
The investigators aim to validate if a digital tool for increased self-management of chronic pain can improve the quality of life for patients with chronic pain. The validation is based on the change in pain interference (Quality of life), pain intensity, physical functioning, depression, and anxiety based on self-reported information from baseline to study end.
Detailed description
Chronic pain is today an increasing health problem in both Europe and US, with an estimation of about 90 million people affected in Europe and 100 million people in US, or 20-30% of the adult population around the world. Chronic pain is defined as a condition that lasts for at least three to six months, after the normal healing period of an injury. Medical interventions offered in clinics around the globe are unfortunately not giving the results needed to give back the quality of life the patients had prior to the onset of the pain. The treatments offered today do sometimes reduce pain, but the effect is minor, and new treatment regimens are needed. Recent quality assurance registry measurements in Sweden has shown that patient taken part of multi modal treatment regimens, such as the acceptance and commitment therapy, (ACT) show that less then 40% of the patients have a decline in the pain level of 1 level on the VAS scale, 55% has no effect. The study objective is to evaluate how the use of a digital pain coach, based on artificial intelligence that improves the self-management of pain will decrease the pain interference and thereby increase QoL among chronic pain patients, as measured by PROMIS pain interference 6a. This study will compare the improvement of quality of life by a decrease in pain interference, measured by PROMIS, in patients who follow their traditional treatment plan provided by the Pain Clinic with the addition of using a web application for increased self management of pain. The theory behind the study and the development of the device is supported by previously known data, showing that self-management has an effect and is important to the treatment by helping patients to believe in their own capacity to control their pain. The present investigation aims at exploring the effect of including digital tool as an add on to standard treatment and rehabilitation at the physiotherapy program at the clinic and will measure the effect it has on: 1. Decreased pain interference 2. Improved management of long-term pain and its consequences. Hence self management of pain 3. Increased function in daily life with the best possible activity and participation level 4. Improved experience of health-related quality of life 5. Decreased pain experience
Interventions
DEVICEPainDrainerTM
Self management digital tool for chronic pain
Sponsors
Skane University Hospital
Lund University
PainDrainer AB
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)
Masking description
Parallel study, single blinded
Intervention model description
Parallel study, single blinded
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Have a pain condition that requires analysis and rehabilitation at a specialist clinic * \>18 years of age * Be medically investigated, with adequate pharmacological treatment, and do not have any other medical examination or ongoing illness that hinders participation in the physiotherapy program at VO Neurosurgery and Pain rehabilitation, Skåne University Hospital, Lund * Meet the criteria for inclusion in the physiotherapy program: Have a chronic (\> 3 months) state of pain with local, regional or spread location, where the pain is judged to be reduced by physiotherapeutic measures * Being included in the physiotherapy program, at VO Neurosurgery and Pain rehabilitation, Skåne University Hospital, Lund * Have the knowledge and proficiency to use a smart phone, tablet or computer
Exclusion criteria
* Severe or acute psychiatric illness, severe anxiety or depression
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain interference | 6 and 12 weeks from baseline | Change from baseline in pain interference (QoL), measured by PROMIS Pain Interference 4a . Measure of the amount of interference pain causes in life; range 4-20; higher is worse |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Physical function | 6 and 12 weeks from baseline | Change from baseline in physical function, measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Physical function 4a. Measure of the impact of a condition on physical function; range 4-20; Raw scores range from 4-20 with higher scores represent better functioning. |
| Depression | 6 and 12 weeks from baseline | Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress-Depression 4a. Measures the extent to which patients experience depressive symptoms over the past 7 days. Raw scores range from 4-20 with higher scores represent worse symptomatology. |
| Anxiety | 6 and 12 weeks from baseline | Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Anxiety 4a. Measures the extent to which patients experience anxiety symptoms over the past 7 days. Raw scores range from 4-20 higher scores represent worse symptomatology. |
| Pain severity | 6 and 12 weeks from baseline | Change from Baseline in the 7 day average pain intensity. Measured by NRS using Pain Intensity Numerical Rating Scale (NRS) (0=no pain, 10=pain as bad as you can imagine) |
| Sleep disturbance | 6 and 12 weeks from baseline | Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep disturbance 4a Measures the extent to which patients experience Sleep disturbance over the past 7 days. Raw scores range from 4-20 with higher scores represent worse symptomatology. |
| Ability to Participate in Social Roles and Activities | 6 and 12 weeks from baseline | Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Ability to Participate in Social Roles and Activities 4a. Measures the extent to which patients ability to participate in social roles and activities over the past 7 days. Raw scores range from 4-20 with higher scores represent better functioning. |
| Fatigue | 6 and 12 weeks from baseline | Change from Baseline measured with Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue 4a Measures the extent to which patients experience fatigue symptoms over the past 7 days. Raw scores range from 4-20 with higher scores represent worse symptomatology. |
Countries
Sweden
Outcome results
None listed